1. Schrödinger will participate in Jefferies Global Healthcare Conference on June 4, 2025. 2. The event will feature a live webcast, accessible for 90 days post-event. 3. Schrödinger's platform enhances drug development through advanced molecular discovery. 4. The company operates globally with a significant R&D investment over 30 years. 5. Three oncology programs are currently in clinical stages.
Participation in a major healthcare conference raises visibility and investor interest. Historical examples show similar events often lead to positive stock momentum.
The event could attract investor attention and discussion around Schrödinger’s advancements, especially in oncology.
The immediate proximity of the event suggests a quick influence on stock momentum. However, long-term impact will depend on subsequent announcements or developments at the conference.
NEW YORK--(BUSINESS WIRE)-- Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference. The live presentation will take place on Wednesday, June 4, 2025 at 1:25 p.m. E.T.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the event.
About Schrödinger
Schrödinger is transforming molecular discovery with its computational platform, which enables the discovery of novel, highly optimized molecules for drug development and materials design. Schrödinger’s software platform is built on more than 30 years of R&D investment and is licensed by biotechnology, pharmaceutical and industrial companies, and academic institutions around the world. Schrödinger also leverages the platform to advance a portfolio of collaborative and proprietary programs and is advancing three clinical-stage oncology programs. Founded in 1990, Schrödinger has approximately 800 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.